Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients
Authors
Keywords
-
Journal
CLINICAL MICROBIOLOGY REVIEWS
Volume 27, Issue 4, Pages 753-782
Publisher
American Society for Microbiology
Online
2014-10-02
DOI
10.1128/cmr.00022-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interspecific Small Molecule Interactions between Clinical Isolates of Pseudomonas aeruginosa and Staphylococcus aureus from Adult Cystic Fibrosis Patients
- (2014) Alexandre Fugère et al. PLoS One
- Cystic Fibrosis Pulmonary Guidelines
- (2013) Peter J. Mogayzel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics and Pharmacodynamics of Once-Daily Administration of Intravenous Tobramycin in Adult Patients with Cystic Fibrosis Hospitalized for an Acute Pulmonary Exacerbation
- (2013) Jill M. Butterfield et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Microbial Persistence and the Road to Drug Resistance
- (2013) Nadia R. Cohen et al. Cell Host & Microbe
- Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
- (2013) Heino Stass et al. CLINICAL DRUG INVESTIGATION
- Staphylococcus aureus Small-Colony Variants Are Independently Associated With Worse Lung Disease in Children With Cystic Fibrosis
- (2013) Daniel J. Wolter et al. CLINICAL INFECTIOUS DISEASES
- Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial
- (2013) Ivanka Galeva et al. CURRENT MEDICAL RESEARCH AND OPINION
- Panton-Valentine leukocidin (PVL) gene carriage among Staphylococcus aureus strains with SCCmec types I, III, IV, and V recovered from cystic fibrosis pediatric patients in Brazil
- (2013) Danielle Ferreira Lima et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Diversity of -lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study
- (2013) C. Llanes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data
- (2013) Laetitia G. Garcia et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa
- (2013) D. M. Hermes et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis
- (2013) E.A. Champion et al. PEDIATRIC PULMONOLOGY
- Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient
- (2013) Matthew L. Workentine et al. PLoS One
- Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts
- (2013) S. Damkiaer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment of Pseudomonas andStaphylococcusBronchopulmonary Infection in Patients with Cystic Fibrosis
- (2013) Rashmi Ranjan Das et al. TheScientificWorldJOURNAL
- Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection
- (2013) J P Clancy et al. THORAX
- Antibiotic and Anti-Inflammatory Therapies for Cystic Fibrosis
- (2013) J. F. Chmiel et al. Cold Spring Harbor Perspectives in Medicine
- The Cystic Fibrosis Airway Microbiome
- (2013) S. V. Lynch et al. Cold Spring Harbor Perspectives in Medicine
- Aerosolised levofloxacin in cystic fibrosis
- (2013) Gerd Döring et al. Expert Opinion on Orphan Drugs
- Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation
- (2013) Katherine E Price et al. Microbiome
- In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients
- (2013) D. R. VanDevanter et al. Journal of the Pediatric Infectious Diseases Society
- Inhaled Aztreonam Lysine for Cystic Fibrosis Pulmonary Disease–Related Outcomes
- (2012) Kimberly A Pesaturo et al. ANNALS OF PHARMACOTHERAPY
- Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target
- (2012) Marilyn N. Martinez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Relative Contributions of Physical Structure and Cell Density to the Antibiotic Susceptibility of Bacteria in Biofilms
- (2012) Amy E. Kirby et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The cystic fibrosis airway microbiome
- (2012) Harvey R. Rabin et al. CURRENT OPINION IN PULMONARY MEDICINE
- Colistin: an update on the antibiotic of the 21st century
- (2012) Silpak Biswas et al. Expert Review of Anti-Infective Therapy
- Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example
- (2012) A. Dalhoff INFECTION
- Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model
- (2012) S. H. Zinner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evolution in Fast Forward: a Potential Role for Mutators in Accelerating Staphylococcus aureus Pathoadaptation
- (2012) G. S. Canfield et al. JOURNAL OF BACTERIOLOGY
- A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis
- (2012) Kavi J. Littlewood et al. Journal of Cystic Fibrosis
- Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
- (2012) M.N. Hurley et al. Journal of Cystic Fibrosis
- The challenges and promises of new therapies for cystic fibrosis: Figure 1.
- (2012) Gerald B. Pier JOURNAL OF EXPERIMENTAL MEDICINE
- Sub-lethal concentrations of antibiotics increase mutation frequency in the cystic fibrosis pathogenPseudomonas aeruginosa
- (2012) C.G. Nair et al. LETTERS IN APPLIED MICROBIOLOGY
- In Vitro Antimicrobial Activity of “Last-Resort” Antibiotics Against Unusual Nonfermenting Gram-Negative Bacilli Clinical Isolates
- (2012) Herve Jacquier et al. Microbial Drug Resistance
- Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones
- (2012) Chris Stockmann et al. PEDIATRIC PULMONOLOGY
- The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations
- (2012) Anthony A. Fodor et al. PLoS One
- Decade-long bacterial community dynamics in cystic fibrosis airways
- (2012) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
- (2012) Antje Schuster et al. THORAX
- Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience
- (2012) Franziska Anne Stressmann et al. THORAX
- Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis withPseudomonas aeruginosa
- (2011) David E. Geller et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- ComparativeIn VitroActivities of the Novel Antibacterial Finafloxacin against Selected Gram-Positive and Gram-Negative Bacteria Tested in Mueller-Hinton Broth and Synthetic Urine
- (2011) Axel Dalhoff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dynamics of Mutator and Antibiotic-Resistant Populations in a Pharmacokinetic/Pharmacodynamic Model of Pseudomonas aeruginosa Biofilm Treatment
- (2011) María D. Macià et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects
- (2011) David E. Geller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Quantification of Amikacin in Bronchial Epithelial Lining Fluid in Neonates
- (2011) C. Tayman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis
- (2011) Niels Høiby BMC Medicine
- Colistin Penetration in the Alveolar Lining Fluid of Critically Ill Patients Treated With IV Colistimethate Sodium: Response
- (2011) Roberto Imberti et al. CHEST
- Colistin Penetration in the Alveolar Lining Fluid of Critically Ill Patients Treated With IV Colistimethate Sodium
- (2011) Nikolaos Markou et al. CHEST
- Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
- (2011) A. R. Hauser et al. CLINICAL MICROBIOLOGY REVIEWS
- Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
- (2011) Johan W. Mouton et al. DRUG RESISTANCE UPDATES
- Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia
- (2011) G Christopher Wood Expert Review of Anti-Infective Therapy
- Spatial distribution of microbial communities in the cystic fibrosis lung
- (2011) Dana Willner et al. ISME Journal
- Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
- (2011) David E. Geller et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes
- (2011) Evgeny A. Idelevich et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI)
- (2011) C. M. Oermann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bacteriophages as vehicles of the resistome in cystic fibrosis
- (2011) J. M. Rolain et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Heteroresistance to Cephalosporins and Penicillins in Acinetobacter baumannii
- (2011) K.-H. Hung et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Staphylococcus aureus with decreased susceptibility to glycopeptides in cystic fibrosis patients
- (2011) Anne Filleron et al. Journal of Cystic Fibrosis
- 217* A multi-cycle open label study of nebulized liposomal amikacin (Arikace(tm)) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
- (2011) P. Minic et al. Journal of Cystic Fibrosis
- Review: Staphylococcus aureus and MRSA in cystic fibrosis
- (2011) Christopher H. Goss et al. Journal of Cystic Fibrosis
- Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
- (2011) C.E. Wainwright et al. Journal of Cystic Fibrosis
- Epistatic Roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in Coping with Reactive Oxygen Species-Induced DNA Damage
- (2011) Laurie H. Sanders et al. PLoS One
- Adaptive Evolution of Staphylococcus aureus during Chronic Endobronchial Infection of a Cystic Fibrosis Patient
- (2011) Paul R. McAdam et al. PLoS One
- Positive Signature-Tagged Mutagenesis in Pseudomonas aeruginosa: Tracking Patho-Adaptive Mutations Promoting Airways Chronic Infection
- (2011) Irene Bianconi et al. PLoS Pathogens
- Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronicPseudomonas aeruginosainfection in cystic fibrosis
- (2011) Michael D Parkins et al. Expert Review of Respiratory Medicine
- Persister Cells
- (2010) Kim Lewis Annual Review of Microbiology
- Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers
- (2010) J. B. Bulitta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
- (2010) P. J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
- (2010) A. Oliver et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Changing Microbial Epidemiology in Cystic Fibrosis
- (2010) J. J. LiPuma CLINICAL MICROBIOLOGY REVIEWS
- Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients
- (2010) V. Cafiso et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine
- (2010) J Stuart Elborn et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pseudomonas aeruginosabiofilms in cystic fibrosis
- (2010) Niels Høiby et al. Future Microbiology
- Inhaled Anti-infective Agents: Emphasis on Colistin
- (2010) A. Michalopoulos et al. INFECTION
- Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones
- (2010) Axel Dalhoff et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy
- (2010) Antonio Oliver INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Adaptation of Staphylococcus aureus to the cystic fibrosis lung
- (2010) Christiane Goerke et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
- (2010) D. Macdonald et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis
- (2010) M. C. Roberts et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Streptococcus milleri Population of a Cystic Fibrosis Clinic Reveals Patient Specificity and Intraspecies Diversity
- (2010) C. D. Sibley et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
- (2010) Michael W. Konstan et al. Journal of Cystic Fibrosis
- Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance
- (2010) Tatsuo Yamamoto et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ciprofloxacin Hydrochloride
- (2010) M.E. Olivera et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis andPseudomonas
- (2010) Terry L. Noah et al. PEDIATRIC PULMONOLOGY
- Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: The EVOLVE trial
- (2010) Michael W. Konstan et al. PEDIATRIC PULMONOLOGY
- An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis
- (2010) Christopher M. Oermann et al. PEDIATRIC PULMONOLOGY
- Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008
- (2010) Julia Emerson et al. PEDIATRIC PULMONOLOGY
- Consensus Summary of Aerosolized Antimicrobial Agents: Application of Guideline Criteria
- (2010) Jennifer Le et al. PHARMACOTHERAPY
- Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
- (2010) Michael J. Cox et al. PLoS One
- Quorum Sensing and Virulence of Pseudomonas aeruginosa during Lung Infection of Cystic Fibrosis Patients
- (2010) Thomas Bjarnsholt et al. PLoS One
- Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy
- (2010) Geraint B. Rogers et al. TRENDS IN MICROBIOLOGY
- Nutrient Availability as a Mechanism for Selection of Antibiotic Tolerant Pseudomonas aeruginosa within the CF Airway
- (2010) Lucas R. Hoffman et al. PLoS Pathogens
- Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa
- (2010) Thilo Köhler et al. PLoS Pathogens
- Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection
- (2009) O. O. Okusanya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due to Pseudomonas aeruginosa
- (2009) M. Sabet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic Fibrosis
- (2009) P. King et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models
- (2009) R. V. Dudhani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
- (2009) M. D. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Small-Colony Variant Selection as a Survival Strategy for Staphylococcus aureus in the Presence of Pseudomonas aeruginosa
- (2009) L. Biswas et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage
- (2009) Jean-Marc Rolain et al. Biology Direct
- Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
- (2009) George Z. Retsch-Bogart et al. CHEST
- A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving Breakpoints
- (2009) A. Dalhoff et al. INFECTION
- Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis
- (2009) M. I. Gillham et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
- (2009) D. L. MacLeod et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus
- (2009) Harry Heijerman et al. Journal of Cystic Fibrosis
- Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations
- (2009) J. L. Fothergill et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Effect of mutatorP. aeruginosaon antibiotic resistance acquisition and respiratory function in cystic fibrosis
- (2009) Agnes Ferroni et al. PEDIATRIC PULMONOLOGY
- Extended-Interval Once-Daily Dosing of Aminoglycosides in Adult and Pediatric Patients with Cystic Fibrosis
- (2009) William A Prescott et al. PHARMACOTHERAPY
- Aerosol Antibiotics in Cystic Fibrosis
- (2009) David E Geller Respiratory Care
- Persistent Methicillin-resistantStaphylococcus aureusand Rate of FEV1Decline in Cystic Fibrosis
- (2008) Elliott C. Dasenbrook et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhaled Aztreonam Lysine for Chronic AirwayPseudomonas aeruginosain Cystic Fibrosis
- (2008) Karen S. McCoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Thymidine-Dependent Small-Colony-Variant Phenotype Is Associated with Hypermutability and Antibiotic Resistance in Clinical Staphylococcus aureus Isolates
- (2008) S. Besier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa
- (2008) M. E. Skindersoe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Complex Ciprofloxacin Resistome Revealed by Screening a Pseudomonas aeruginosa Mutant Library for Altered Susceptibility
- (2008) E. B. M. Breidenstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Complex Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Isolates From Children With Cystic Fibrosis in the Era of Epidemic Community-Associated Methicillin-Resistant S aureus
- (2008) Daniel Glikman et al. CHEST
- Pseudomonas aeruginosa diversity in distinct paediatric patient groups
- (2008) G.A. Tramper-Stranders et al. CLINICAL MICROBIOLOGY AND INFECTION
- Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity inPseudomonas aeruginosa
- (2008) Alexandros Ikonomidis et al. FEMS MICROBIOLOGY LETTERS
- Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media
- (2008) J. D. Perry et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation
- (2008) A. Molina et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
- (2008) P. J. Bergen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Increased mutability of Pseudomonas aeruginosa in biofilms
- (2008) K. Driffield et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A randomized placebo-controlled study of nebulized liposomal amikacin (Arikace™) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
- (2008) L. Dupont et al. Journal of Cystic Fibrosis
- Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme
- (2008) Wing Yau et al. JOURNAL OF INFECTION
- Diffusible signals and interspecies communication in bacteria
- (2008) R. P. Ryan et al. MICROBIOLOGY-SGM
- A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients
- (2008) C. D. Sibley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recurrent exacerbations affect FEV1 decline in adult patients with cystic fibrosis
- (2008) Anna Amadori et al. RESPIRATORY MEDICINE
- Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections
- (2008) Christopher D. Sibley et al. PLoS Pathogens
- Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis
- (2007) Giuseppe Valenza et al. Journal of Cystic Fibrosis
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started